Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

HLTRF Stock Latest News

Company AnnouncementsHLS Partners with Bayer to Commercialize VERQUVO in Canada2d ago
HLS Therapeutics upgraded to Buy from Hold at CanaccordThe FlyHLS Therapeutics upgraded to Buy from Hold at Canaccord2M ago
The FlyHLS Therapeutics upgraded to Strong Buy from Outperform at Raymond James2M ago
RatingsHLS Therapeutics Earns Reiterated Buy Rating from David Martin on Strong 2Q Results and Clozaril Recovery; C$12 Price Target Maintained2M ago
HLS Therapeutics to Highlight CNS and Cardiovascular Portfolio at Bloom Burton Investor ConferenceCompany AnnouncementsHLS Therapeutics to Highlight CNS and Cardiovascular Portfolio at Bloom Burton Investor Conference6M ago
RatingsHLS Therapeutics: Near-Term Softness Masking NILEMDO-Driven Growth Upside, Supporting Buy Rating7M ago
The FlyHLS Therapeutics price target lowered to C$4.45 from C$4.75 at Stifel7M ago
HLS Therapeutics Sets March 12 Date for Fiscal 2025 Results and Investor CallCompany AnnouncementsHLS Therapeutics Sets March 12 Date for Fiscal 2025 Results and Investor Call8M ago
The FlyHLS Therapeutics price target raised to C$4.75 from C$4 at Stifel10M ago